During the past decade, Smilow Cancer Hospital Phase 1 Unit conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Smilow Cancer Hospital Phase 1 Unit" are "Ovarian Cancer" (2 trials), "Prostate Cancer" (2 trials), "Solid Tumors" (2 trials), "Adenocarcinoma of Lung" (1 trials) and "Advanced Solid Tumors" (1 trials). Many other conditions were trialed in "Smilow Cancer Hospital Phase 1 Unit" in a lesser frequency.

Most popular intervention types in "Smilow Cancer Hospital Phase 1 Unit" are "Drug" (4 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fulvestrant" (2 trials), "Letrozole" (2 trials), "PF-07220060" (2 trials), "ADCT-301" (1 trials) and "Enzalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Smilow Cancer Hospital Phase 1 Unit" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Smilow Cancer Hospital Phase 1 Unit". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Smilow Cancer Hospital Phase 1 Unit, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Smilow Cancer Hospital Phase 1 Unit, 5 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".